Radiolabeled peptides are of increasing interest in nuclear oncology. Special emphasis has
been given to the development of peptides labeled with positron emitters. Among these, 68 …

Positron emission tomography (PET) is becoming a dominating method in the field of
molecular imaging. Most commonly used radionuclides are accelerator produced 11 C and …

Abstract 68 Ge/68 Ga generators provide cyclotron-independent access to positron emission
tomography (PET) radiopharmaceuticals. We describe a system which allows the safe and …

Purpose A new field of interest is the application of 68 Ga-labelled DOTA-conjugated
peptides for positron emission tomography (PET). The commercially available or house …

The use of 68Ga-labeled peptides in diagnosis, dosimetry, therapy planning and follow-up
of response to chemo-and radiotherapy requires accurate quantification of tracer binding …

Abstract Gallium-68 (68 Ga) is a generator-produced radionuclide with a short half-life (t ½=
68 min) that is particularly well suited for molecular imaging by positron emission …

PET (positron emission tomography) is a powerful diagnostic and imaging technique which
requires short‐lived positron emitting isotopes. The most commonly used are accelerator …

Background Generator-produced 68 Ga has attracted increasing interest for radiolabelling
peptides used in PET applications. So far, the synthesis of 68 Ga-peptide …

Abstract Background Currently, 68 Ga-labeled 1, 4, 7, 10-tetraazacyclododecane-tetraacetic
acid (DOTA)-peptides are the most widely used class of 68 Ga radiotracers for PET …

The generator-produced positron-emitting 68Ga (T 1/2= 68 min) is of potential interest for
clinical PET. 68Ga as a metallic cation is suitable for complexation reactions with chelators …